Cite
Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma
MLA
Kengo Kawaguchi, et al. “Viable Tumor Cell Density after Neoadjuvant Chemotherapy Assessed Using Deep Learning Model Reflects the Prognosis of Osteosarcoma.” Npj Precision Oncology, vol. 8, no. 1, Jan. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41698-024-00515-y.
APA
Kengo Kawaguchi, Kazuki Miyama, Makoto Endo, Ryoma Bise, Kenichi Kohashi, Takeshi Hirose, Akira Nabeshima, Toshifumi Fujiwara, Yoshihiro Matsumoto, Yoshinao Oda, & Yasuharu Nakashima. (2024). Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma. Npj Precision Oncology, 8(1), 1–9. https://doi.org/10.1038/s41698-024-00515-y
Chicago
Kengo Kawaguchi, Kazuki Miyama, Makoto Endo, Ryoma Bise, Kenichi Kohashi, Takeshi Hirose, Akira Nabeshima, et al. 2024. “Viable Tumor Cell Density after Neoadjuvant Chemotherapy Assessed Using Deep Learning Model Reflects the Prognosis of Osteosarcoma.” Npj Precision Oncology 8 (1): 1–9. doi:10.1038/s41698-024-00515-y.